PTGER4 and triple-A syndrome: Here, we demonstrate the effects of the selective EP4 antagonist CJ‐42794 [(S)‐4‐(1‐(5‐chloro‐2‐(4‐fluorophenyoxy) benzamido)ethyl) benzoic acid] on two types of AAA mouse models and hAASMCs.